Is Amylyx Pharmaceuticals, Inc. overvalued?

Amylyx Pharmaceuticals, Inc. (AMLX) — key valuation metrics and fundamentals.

No verdict

Price

$21.63

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.40B

Dividend yield

4.3%

Return on equity

-52.9%

Sector

Healthcare

Fair value compares AMLX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks